|
NVNO enVVeno Medical Corp 1661053 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,849,000.00 |
| Balance Sheet |
|
Current Assets
|
$25,489,000.00 |
|
Assets
|
$26,097,000.00 |
|
Current Liabilities
|
$2,143,000.00 |
|
Liabilities
|
$2,350,000.00 |
|
Equity
|
$23,747,000.00 |
|
Shares Out
|
656000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,238,000.00 |
|
Investing Cash Flow
|
$2,770,000.00 |
| Market Analysis |
Market Cap
|
$6,973,280.00 |
|
Price
|
$10.69 |
|
BVPS
|
36.20 |
|
PB
|
0.29 |
|
EPS
|
-5.89 |
|
FCF
|
$-3,243,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NVNO documents filed with the SEC.
NVNO Filings
Clear
